GGrantIndex
Sort

78,016 grants matching breast cancer

Genetic Alterations That Initiate Follicular Thyroid Carcinogenesis

$590,944
Charis Eng · Ohio State University · P01 · FY2012 · CA

Developing DOSI Technology for Monitoring Response To Breast Cancer Chemotherapy

$590,943
Bruce J Tromberg · University Of California-Irvine · R01 · FY2011 · CA

Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors

$590,940
Siobhan Marie Phillips · Northwestern University At Chicago · R37 · FY2023 · CA

Simulating Protein Structures, Complexes, And Dynamics

$590,933
Peter J Steinbach · Center For Information Technology · ZIA · FY2015 · CT

A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial

$590,892
Tamara J Somers · Duke University · R01 · FY2024 · CA

Predicting Endocrine Therapy Response In Male Breast Tumors

$590,870
Philip M Spanheimer · Univ Of North Carolina Chapel Hill · R37 · FY2025 · CA

Mechanisms of Motor Superperformance

$590,870
Juan M. Pascual · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS

Identification of microRNA Biomarkers for Colon Cancer Recurrence Risk Stratifica

$590,860
Elizabeth Mambo · Asuragen, Inc. · R44 · FY2011 · CA

Racial and Socioeconomic Disparities in Breast Cancer Diagnostic Work Up and Outcomes

$590,818
Christoph I Lee · University Of Washington · R01 · FY2022 · CA

Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS

$590,778
Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Comparative Modeling: Informing Breast Cancer Control Practice & Policy

$590,778
Jeanne Mandelblatt · Georgetown University · U01 · FY2015 · CA

A PROGRAMMABLE DNA ARRAY SYNTHESIZER

$590,769
Xeotron Corporation · R44 · FY2000 · HG

Dynamics of Vascular Microbubbles and Microdroplets in Gas Embolotherapy

$590,757
Joseph L Bull · University Of Michigan At Ann Arbor · R01 · FY2014 · EB

Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s

$590,708
Sean Vahram Tavtigian · University Of Utah · R01 · FY2022 · CA

Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention

$590,659
Xiangxi Mike Xu · Fox Chase Cancer Center · P50 · FY2007 · CA

A novel therapeutic strategy to target mutant p53

$590,625
Xinbin Chen · University Of California At Davis · R01 · FY2025 · CA

ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement

$590,586
Ruth D Etzioni · Fred Hutchinson Cancer Research Center · UH3 · FY2020 · CA

Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository

$590,562
Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA

Variations in Colonoscopy Screening: A Population Based Study

$590,457
Lynn F Butterly · Dartmouth College · R01 · FY2012 · CA

Promoting tumor cell apoptosis by death ligands

$590,400
Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue

$590,368
Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA

Comparative Effectiveness of Interventions to Improve Screening Among Rural Women

$590,351
Electra D. Paskett · Ohio State University · R01 · FY2019 · CA

Novel RORgamma antagonists for inflammation and autoimmune disease

$590,333
F Javier Piedrafita · Torrey Pines Inst For Molecular Studies · R01 · FY2016 · AI

Endosome-mitochondria interactions in breast cancer cells

$590,286
Margarida Barroso · Albany Medical College · R01 · FY2020 · CA

Axonal transport and chemotherapy induced peripheral neuropathy

$590,280
Rosalind A Segal · Dana-Farber Cancer Inst · R01 · FY2025 · CA